Analystreport

VBI Vaccines Inc (NASDAQ: VBIV) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating.

VBI Vaccines, Inc. - Ordinary Shares  (VBIV) 
Last vbi vaccines, inc. - ordinary shares earnings: 11/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: vbivaccines.com/investors